INVO BIOSCIENCE, INC. (OTCMKTS:IVOB) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02(a)(3)(iii) which requires the Company to file any
letter received from the director. Attached is the letter INVO
Bioscience received.
|
Item 9.01
|
Financial Statements and Exhibits
|
|
Exhibit Number
|
Description
|
|
|
17.1
|
Response letter to original Form 8-K filing from C Ranoux
dated April 11, 2017. |
About INVO BIOSCIENCE, INC. (OTCMKTS:IVOB)
INVO Bioscience, Inc. is a medical device company. The Company is focused on creating various treatments for patients diagnosed with infertility. The Company’s product, the INVOcell, is a medical device used in infertility treatment and is considered as an assisted reproductive technology (ART). INVOcell is an intravaginal culture (IVC) system used for preparing, holding and transferring human gametes or embryos during vaginal in vitro fertilization or intravaginal culture procedures (IVF/IVC). The INVOcell system consists of various components: INVOcell Culture Device, INVOcell Retention Device and INVOcell Holding Block. The INVO Procedure is a fertility treatment option allowing fertilization and early embryo development to take place inside the woman’s body. The INVO Procedure is an IVC or in vivo incubation assisted reproduction technique available.
INVO BIOSCIENCE, INC. (OTCMKTS:IVOB) Recent Trading Information
INVO BIOSCIENCE, INC. (OTCMKTS:IVOB) closed its last trading session 00.000 at 0.370 with 37,773 shares trading hands.
